6133.HK
Vital Innovations Holdings Limited [6133.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6133.HK Stock Summary
In the News
6133.HK Financial details
Company Rating
Sell
Market Cap
194.65M
Income
-17.57M
Revenue
745.06M
Book val./share
0.61
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
27
Optionable
No
Shortable
Yes
Earnings
30 Aug 2023
P/E
-10.26
Forward P/E
-
PEG
5.94
P/S
0.16
P/B
0.34
P/C
11.45
P/FCF
11.59
Quick Ratio
0.39
Current Ratio
6.46
Debt / Equity
0.05
LT Debt / Equity
0
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-17.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.68%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-3%
ROC
-0.03%
Gross Margin
-
Oper. Margin
-2%
Profit Margin
-2%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.2-0.7
52W High
-
52W Low
-
RSI
47
Rel Volume
4.58
Avg Volume
4.8K
Volume
22K
Perf Week
-4.18%
Perf Month
0%
Perf Quarter
-
Perf Half Y
-10.2%
-
-
-
-
Beta
0.231
-
-
Volatility
0.02%, 0.01%
Prev Close
0%
Price
0.229
Change
14.5%
6133.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.07 | 0.96 | 1.04 | 0.79 | 1.28 | |
| Net income per share | 0.02 | 0 | -0.11 | -0.02 | -0.02 | |
| Operating cash flow per share | -0.02 | -0.82 | 0 | -0.02 | 0.02 | |
| Free cash flow per share | -0.02 | -0.82 | 0 | -0.02 | 0.02 | |
| Cash per share | 0.83 | 0.06 | 0.06 | 0.03 | 0.04 | |
| Book value per share | 0.87 | 0.78 | 0.66 | 0.64 | 0.62 | |
| Tangible book value per share | 0.87 | 0.78 | 0.66 | 0.64 | 0.62 | |
| Share holders equity per share | 0.87 | 0.78 | 0.66 | 0.64 | 0.62 | |
| Interest debt per share | 0.01 | 0.03 | 0.03 | 0.02 | 0.01 | |
| Market cap | 492.28M | 269.43M | 336.18M | 201.18M | 177.15M | |
| Enterprise value | 472.38M | 240.72M | 302.93M | 189.9M | 148.57M | |
| P/E ratio | 33.84 | -102.02 | -3.55 | -9.49 | -10.14 | |
| Price to sales ratio | 0.54 | 0.33 | 0.38 | 0.3 | 0.16 | |
| POCF ratio | -35.4 | -0.39 | 86.02 | -10.2 | 11.46 | |
| PFCF ratio | -35.37 | -0.39 | 86.02 | -10.2 | 11.46 | |
| P/B Ratio | 0.66 | 0.41 | 0.6 | 0.37 | 0.34 | |
| PTB ratio | 0.66 | 0.41 | 0.6 | 0.37 | 0.34 | |
| EV to sales | 0.52 | 0.3 | 0.34 | 0.28 | 0.14 | |
| Enterprise value over EBITDA | 46.26 | -35.98 | -3.06 | -10.04 | -9.57 | |
| EV to operating cash flow | -33.96 | -0.35 | 77.52 | -9.63 | 9.61 | |
| EV to free cash flow | -33.94 | -0.35 | 77.52 | -9.63 | 9.61 | |
| Earnings yield | 0.03 | -0.01 | -0.28 | -0.11 | -0.1 | |
| Free cash flow yield | -0.03 | -2.57 | 0.01 | -0.1 | 0.09 | |
| Debt to equity | 0 | 0.03 | 0.04 | 0.03 | 0.02 | |
| Debt to assets | 0 | 0.03 | 0.03 | 0.02 | 0.01 | |
| Net debt to EBITDA | -1.95 | 4.29 | 0.34 | 0.6 | 1.84 | |
| Current ratio | 6.26 | 8.28 | 4.79 | 6.57 | 6.46 | |
| Interest coverage | 11.71 | -8.24 | -146.18 | -37.43 | -20.28 | |
| Income quality | -0.96 | 124.31 | -0.04 | 0.96 | -0.88 | |
| Dividend Yield | 0 | 0.28 | 0 | 0 | 0 | |
| Payout ratio | 0 | -28.22 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.12 | 0 | 0 | 0 | -0.01 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.58 | 0.23 | 1.29 | 0.6 | 0.53 | |
| ROIC | 0.02 | -0.01 | -0.17 | -0.04 | -0.03 | |
| Return on tangible assets | 0.02 | 0 | -0.13 | -0.03 | -0.03 | |
| Graham Net | 0.68 | -0.04 | -0.09 | -0.07 | -0.06 | |
| Working capital | 740.27M | 658.33M | 561.76M | 540.41M | 522.86M | |
| Tangible asset value | 740.4M | 659.83M | 562.22M | 541.65M | 524.1M | |
| Net current asset value | 740.27M | 658.15M | 561.48M | 538.57M | 522.3M | |
| Invested capital | 0 | 0.03 | 0.04 | 0.03 | 0.02 | |
| Average receivables | 0 | 0.5 | 54.5K | 4.16M | 4.13M | |
| Average payables | 88.45M | 48.74M | 21.34M | 20.31M | 9.62M | |
| Average inventory | 33.86M | 15.98M | 16.24M | 22.45M | 12.91M | |
| Days sales outstanding | 0 | 0 | 0.05 | 4.46 | 0.01 | |
| Days payables outstanding | 34.54 | 5.75 | 11.37 | 5.8 | 2.87 | |
| Days of inventory on hand | 10.84 | 2.43 | 10.3 | 9.65 | 2.69 | |
| Receivables turnover | 0 | 815.94M | 8.08K | 81.92 | 27.31K | |
| Payables turnover | 10.57 | 63.44 | 32.1 | 62.92 | 127.18 | |
| Inventory turnover | 33.68 | 150.12 | 35.45 | 37.81 | 135.7 | |
| ROE | 0.02 | 0 | -0.17 | -0.04 | -0.03 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.41 | 0.23 | 0.23 | 0.21 | 0.21 | |
| Net income per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Operating cash flow per share | 0.02 | -0.01 | -0.01 | -0.02 | -0.02 | |
| Free cash flow per share | 0.02 | -0.01 | -0.01 | -0.02 | -0.02 | |
| Cash per share | 0.09 | 0.04 | 0.04 | 0.02 | 0.02 | |
| Book value per share | 0.63 | 0.62 | 0.62 | 0.61 | 0.61 | |
| Tangible book value per share | 0.63 | 0.62 | 0.62 | 0.61 | 0.61 | |
| Share holders equity per share | 0.63 | 0.62 | 0.62 | 0.61 | 0.61 | |
| Interest debt per share | 0.03 | 0 | 0.01 | 0 | 0.03 | |
| Market cap | 158.91M | 182.61M | 177.18M | 189.52M | 192.48M | |
| Enterprise value | 112.02M | 145.03M | 148.59M | 170.41M | 199.86M | |
| P/E ratio | -9.02 | -10.45 | -10.14 | -10.72 | -10.89 | |
| Price to sales ratio | 0.45 | 0.93 | 0.9 | 1.08 | 1.09 | |
| POCF ratio | 8.84 | -17.83 | -17.3 | -10.7 | -10.86 | |
| PFCF ratio | 8.84 | -17.82 | -17.29 | -10.69 | -10.86 | |
| P/B Ratio | 0.3 | 0.35 | 0.34 | 0.37 | 0.37 | |
| PTB ratio | 0.3 | 0.35 | 0.34 | 0.37 | 0.37 | |
| EV to sales | 0.32 | 0.74 | 0.76 | 0.97 | 1.14 | |
| Enterprise value over EBITDA | -24.81 | -33.78 | -34.61 | -40.3 | -47.26 | |
| EV to operating cash flow | 6.23 | -14.16 | -14.51 | -9.62 | -11.28 | |
| EV to free cash flow | 6.23 | -14.16 | -14.5 | -9.62 | -11.28 | |
| Earnings yield | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | |
| Free cash flow yield | 0.11 | -0.06 | -0.06 | -0.09 | -0.09 | |
| Debt to equity | 0.05 | 0 | 0.02 | 0 | 0.05 | |
| Debt to assets | 0.04 | 0 | 0.01 | 0 | 0.04 | |
| Net debt to EBITDA | 10.38 | 8.75 | 6.66 | 4.52 | -1.75 | |
| Current ratio | 7.01 | 6.46 | 6.46 | 5.71 | 5.71 | |
| Interest coverage | 0 | 0 | -7.15 | 0 | -7.39 | |
| Income quality | -4.08 | 2.34 | 2.34 | 4.01 | 4.01 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | -0.01 | -0.01 | -0.02 | -0.02 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | |
| ROIC | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Return on tangible assets | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Graham Net | -0.02 | 0.27 | -0.06 | 0.25 | -0.1 | |
| Working capital | 535.01M | 522.86M | 522.86M | 514.26M | 514.26M | |
| Tangible asset value | 532.84M | 524.1M | 524.1M | 515.25M | 515.25M | |
| Net current asset value | 530.41M | 522.3M | 522.3M | 514.09M | 514.09M | |
| Invested capital | 0.05 | 0 | 0.02 | 0 | 0.05 | |
| Average receivables | 0 | 40K | 40K | 40K | 40K | |
| Average payables | 0 | 8.63M | 8.55M | 8.56M | 8.58M | |
| Average inventory | 0 | 291.55M | 291.26M | 303.03M | 302.67M | |
| Days sales outstanding | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Days payables outstanding | 2.25 | 3.94 | 3.94 | 4.41 | 4.41 | |
| Days of inventory on hand | 2.22 | 264.38 | 3.69 | 307.19 | 3.75 | |
| Receivables turnover | 8.74K | 4.92K | 4.92K | 4.4K | 4.4K | |
| Payables turnover | 39.95 | 22.87 | 22.87 | 20.43 | 20.43 | |
| Inventory turnover | 40.51 | 0.34 | 24.4 | 0.29 | 23.98 | |
| ROE | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
6133.HK Frequently Asked Questions
What is Vital Innovations Holdings Limited stock symbol ?
Vital Innovations Holdings Limited is a CN stock and trading under the symbol 6133.HK
What is Vital Innovations Holdings Limited stock quote today ?
Vital Innovations Holdings Limited stock price is $0.229 today.
Is Vital Innovations Holdings Limited stock public?
Yes, Vital Innovations Holdings Limited is a publicly traded company.
Company Profile
- Volume Average 4.8K
- Market Capitalization 194.65M
- Employee 27
- CEO Mr. Shengli Rong
- Headquarters Beijing,CN
- IPO Date 2015-06-26
-
Website
https://www.vitalinno.com 
Vital Innovations Holdings Limited, an investment holding company, designs, develops, manufactures, and sells mobile handsets in Hong Kong. It offers mobile phones, smartphones, and mobile telecommunication related components and accessories, as well as supply chain management, logistics, and other related mobile telecommunication services. The company serves mobile handset suppliers, telecommunication operators, and trading companies in South Asia, Southeast Asia, rest of Asia, Europe, North America, South America, and Africa. It also sells AI and other equipment. The company was formerly known as Vital Mobile Holdings Limited and changed its name to Vital Innovations Holdings Limited in July 2019. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Vital Innovations Holdings Limited is a subsidiary of Winmate Limited.
